J&JPRD s Frank Brown on Build vs. Buy and Chem- vs. Bioinformatics | GenomeWeb

At IBC’s Drug Discovery Technology conference in August, Frank Brown, senior research fellow and chemoinformatics team leader at Johnson & Johnson Pharmaceutical Research & Development, discussed a method his team developed for “virtual” high-throughput screening based on the idea of screening fewer, information-rich compounds.

BioInform recently caught up with Brown to find out more about this method, and to get his thoughts on the interface between cheminformatics and bioinformatics.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.